However, the role of PR activation seems to be a bit controversial, because in some studies, PR activation seems to promote breast cancer, whereas in some studies, progesterone treatment has been shown to be anti-proliferative in ER+/PR+ breast cells [39–41]. The gene discussed is ESR1; the disease is breast cancer.